Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
about
Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton InvolvementInhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma CellsP21Waf1/Cip1 and p27Kip1 are correlated with the development and invasion of prolactinoma.Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.RIZ1 and histone methylation status in pituitary adenomas.
P2860
Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lower PRDM2 expression is asso ...... r recurrence in prolactinomas.
@ast
Lower PRDM2 expression is asso ...... r recurrence in prolactinomas.
@en
type
label
Lower PRDM2 expression is asso ...... r recurrence in prolactinomas.
@ast
Lower PRDM2 expression is asso ...... r recurrence in prolactinomas.
@en
prefLabel
Lower PRDM2 expression is asso ...... r recurrence in prolactinomas.
@ast
Lower PRDM2 expression is asso ...... r recurrence in prolactinomas.
@en
P2093
P2860
P1433
P1476
Lower PRDM2 expression is asso ...... r recurrence in prolactinomas.
@en
P2093
Chuzhong Li
Lichuan Hong
Songbai Gui
Xiaolei Lan
Yazhuo Zhang
P2860
P2888
P356
10.1186/S12885-015-1267-0
P407
P577
2015-04-12T00:00:00Z
P5875
P6179
1031587217